CSIMarket
 
Semler Scientific Inc   (SMLR)
Other Ticker:  
 
 
Price: $30.1700 $-0.19 -0.626%
Day's High: $31.94 Week Perf: -5.75 %
Day's Low: $ 29.80 30 Day Perf: -41.46 %
Volume (M): 100 52 Wk High: $ 53.38
Volume (M$): $ 3,008 52 Wk Avg: $32.25
Open: $30.50 52 Wk Low: $19.35



 Market Capitalization (Millions $) 236
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 68
 Net Income (TTM) (Millions $) 21
 Cash Flow (TTM) (Millions $) 34
 Capital Exp. (TTM) (Millions $) 1

Semler Scientific Inc
Semler Scientific Inc. is a medical device company that specializes in developing and commercializing technology solutions for the early detection and prevention of chronic diseases. The company's flagship product is the CardioHealth Station, which is a non-invasive diagnostic device used to measure arterial stiffness and assess cardiovascular health. This device provides valuable information to healthcare professionals for early intervention and personalized treatment recommendations. Semler Scientific aims to improve patient outcomes and reduce healthcare costs by promoting prevention and proactive care through their innovative technology solutions.


   Company Address: 2340-2348 Walsh Avenue, Suite 2344 Santa Clara 95051 CA
   Company Phone Number: 774-4211   Stock Exchange / Ticker: NASDAQ SMLR
   SMLR is expected to report next financial results on March 22, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Semler Scientific Inc

2. Tax Windfall Boosts Bottom Line

Semler Scientific Inc (SMLR) has been on a phenomenal growth trajectory, as evidenced by their recent financial results for the fiscal interval ending December 31, 2023. The company has seen a remarkable improvement in their earnings per share, with a 33.61% increase to $0.56. This impressive growth has also been reflected in their revenue, which surged by 9.148% to $15.06 million compared to $13.80 million in the prior year.
What sets Semler Scientific Inc apart from its industry peers is its ability to outperform on the revenue front. While the rest of the Medical Equipment & Supplies industry saw a 6.68% increase in revenue during the same reporting period, Semler Scientific Inc managed to achieve a much higher growth rate. Additionally, the company's net income saw a significant increase of 31.25% to $4.221 million, showing strong profitability and financial health.

Semler Scientific Inc

Semler Scientific Inc. Shines with Memorable Revenue Growth, Dominating July-September 2023 Period



Semler Scientific Inc, a prominent player in the Medical Equipment & Supplies industry, has released its financial results for the July to September 30, 2023 fiscal period. The company witnessed impressive revenue growth, improved profitability, and increased net income compared to the same period last year. This article aims to delve into the financial figures, interpret the data, and contextualize Semler Scientific Inc's performance within the industry.
Key Points:
1. Revenue:
- Semler Scientific Inc reported revenue of $16.32 million for the July to September 30, 2023 fiscal period, reflecting a YoY increase of 16.153%. However, the company experienced a QoQ decline of -12.303%.
- Comparatively, the rest of the Medical Equipment & Supplies industry saw a revenue rise of 4.83% during the same period, highlighting Semler's outperformance in the sector.

Semler Scientific Inc

Semler Scientific Inc. Disappoints Investors with Slowing Growth Despite Surge in Revenue and Earnings during Q2 2023

Semler Scientific Inc. recently released its second quarter financial results for 2023, and on the surface, the numbers seem impressive. The company reported a substantial revenue increase of 25.472% to $18.61 million and a profit per share surge of 47.06% to $0.75 per share compared to the same period last year. This certainly outpaces its sector peers, which only showed a 3.97% revenue growth.
However, upon closer analysis, there are several red flags that suggest a bearish outlook for Semler Scientific Inc. For one, while the company's revenue and profit per share may have seen significant increases, these numbers do not necessarily tell the whole story. Sequentially, the company only saw a modest EPS growth of 19.05% from the previous quarter, and revenue only advanced by 2.192%. This indicates a potential slowdown in growth, which could be problematic for investors.

Semler Scientific Inc

Semler Scientific Inc Reports Improved ROE and Advances in Industry Ranking

Semler Scientific Inc, a prominent player in the Medical Equipment & Supplies industry, has announced its financial results for the first quarter of 2023. According to the report, Semler Scientific Inc returned a return on equity (ROE) of 28.98%, which is below their average ROE of 31.15%.
However, the ROE has improved compared to the preceding quarter's 27.54%, due to a growth in net income. While three other companies in the Medical Equipment & Supplies industry had a higher ROE, Semler Scientific Inc's overall ranking has advanced from the fourth quarter of 2022's 568 to 339.






 

Semler Scientific Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Semler Scientific Inc does not provide revenue guidance.

Earnings Outlook
Semler Scientific Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com